567-Patient Study Confirms LMWH Safety in Pregnancy
Flora Peyvandi, former President of ISTH, recently shared an insightful post on X:
”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study.”
Read the full article here.
An article ”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study”, published by Camille Simard et al. in the Journal of Thrombosis and Haemostasis, sheds light on the safety use of low-molecular-weight heparin (LMWH) in pregnancy complicated by acute venous throembolism.
This multinational (Germany;Quebec) cohort study of 567 pregnant women with VTE treated with LMWH provided new data on bleeding risk during pregnancy.
The findings suggest that LMWH type and dosing frequency may not significantly impact bleeding risk, though further research is needed to refine anticoagulation strategies for optimizing maternal outcomes.
More on scientific advancements in the field of thrombosis featured in Hemostasis Today.
-
Jul 14, 2025, 12:32Anticoagulation in Liver Transplant Candidates: Is Apixaban Safe?
-
Jul 14, 2025, 12:30The Heart: Managing Warfarin-Induced Coagulopathy - New Insights into Handling Prolonged INR Levels
-
Jul 14, 2025, 12:26Investing in the Future of Stroke Innovation: SVIN Pilot Grant Empowers Early-Stage Research in Vascular Neurology
-
Jul 14, 2025, 12:22NEJM Publishes BRIDGE-TNK Trial: IV Tenecteplase Before Thrombectomy in Acute Ischemic Stroke
-
Jul 13, 2025, 15:33ISTH Now Accepting Applications for SSC Leadership Roles
-
Jul 14, 2025, 18:253 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
-
Jul 14, 2025, 16:12567-Patient Study Confirms LMWH Safety in Pregnancy
-
Jul 13, 2025, 18:182025 ASH ISTH NBDF WFH monitoring report Confirms Strength of 2021 VWD Diagnosis and Management Guidelines
-
Jul 13, 2025, 17:57Preventing VTE in Cancer, Maintaining Low Bleeding Risk: Reduced-Dose Apixaban
-
Jul 13, 2025, 17:172024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 6, 2025, 21:00From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jul 6, 2025, 11:48Japan's Youth Engagement in Hemophilia Care: Where Even the Doctors Get It – HABIT Summit 2025